期刊论文详细信息
Quantitative Imaging in Medicine and Surgery
Diffusion-weighted EPI- and HASTE-MRI and 18F-FDG-PET-CT early during chemoradiotherapy in advanced head and neck cancer
Lisa van der Putten4  Patricia A. Doornaert2  Charlotte S. Schouten4  C. René Leemans4  Otto S. Hoekstra1  Remco de Bree4  Emile F.I. Comans1  Birgit I. Witte3  Daniel P. Noij1  Jonas A. Castelijns1 
[1] Department of Radiology and Nuclear Medicine,;Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands;Department of Epidemiology and Biostatistics,;Department of Otolaryngology-Head and Neck Surgery,
关键词: Chemoradiotherapy (CRT);    diffusion-weighted magnetic resonance imaging (DW-MRI);    head and neck squamous cell carcinoma (HNSCC);    positron emission tomography (PET);    treatment response;   
DOI  :  10.3978/j.issn.2223-4292.2014.07.15
学科分类:外科医学
来源: AME Publications
PDF
【 摘 要 】

Main problem: Diffusion-weighted MRI (DW-MRI) has potential to predict chemoradiotherapy (CRT) response in head and neck squamous cell carcinoma (HNSCC) and is generally performed using echo-planar imaging (EPI). However, EPI-DWI is susceptible to geometric distortions. Half-fourier acquisition single-shot turbo spin-echo (HASTE)-DWI may be an alternative. This prospective pilot study evaluates the potential predictive value of EPI- and HASTE-DWI and 18F-fluorodeoxyglucose PET-CT (18F-FDG-PET-CT) early during CRT for locoregional outcome in HNSCC.

Methods: Eight patients with advanced HNSCC (7 primary tumors and 25 nodal metastases) scheduled for CRT, underwent DW-MRI (using both EPI- and HASTE-DWI) and 18F-FDG-PET(-CT) pretreatment, early during treatment and three months after treatment. Median follow-up time was 38 months.

Results: No local recurrences were detected during follow-up. Median Apparent Diffusion Coefficient (ADC)EPI-values in primary tumors increased from 77×10�?5 mm2/s pretreatment, to 113×10�?5 mm2/s during treatment (P=0.02), whereas ADCHASTE did not increase (74 and 74 mm2/s, respectively). Two regional recurrences were diagnosed. During treatment, ADCEPI tended to be higher for patients with regional control [(117.3±12.1)×10�?5 mm2/s] than for patients with a recurrence [(98.0±4.2)×10�?5 mm2/s]. This difference was not seen with ADCHASTE. No correlations between ΔADCEPI and ΔSUV (Standardized Uptake Value) were found in the primary tumor or nodal metastases.

Conclusions: HASTE-DWI seems to be inadequate in early CRT response prediction, compared to EPI-DWI which has potential to predict locoregional outcome. EPI-DWI and 18F-FDG-PET-CT potentially provide independent information in the early response to treatment, since no correlations were found between ΔADCEPI and ΔSUV.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912010251039ZK.pdf 12KB PDF download
  文献评价指标  
  下载次数:3次 浏览次数:16次